NEO (NeoGenomics Laboratories) Revenue Growth QoQ

NeoGenomics, Inc. (NEO) aims for dominance in the complex oncology testing segment by integrating its IT platforms into drug development processes. Optimization is achieved through outsourced logistics management and cloud-based data analysis. Production capacities operate at maximum efficiency, upgrading equipment without downtime. The value of 11.50 shows the latest figure, reflecting the percentage change in quarterly revenue on this chart.
NEO (NeoGenomics Inc): analytical breakdowns and indicator data

The critical importance of oncology testing ensures a steady stream of orders for NeoGenomics, Inc. (NEO), minimizing the impact of macroeconomic shocks on operating revenues. A mathematical calculation of the net revenue difference between adjacent periods quantifies this stability, allowing the fundamental business growth trend to be assessed through current quarterly revenue dynamics and the ratio of investment risks to potential returns to be accurately calculated.